Javier A. Villafuerte Gálvez
@JVG_GIMD
Gastroenterologist @BIDMC_GI & @harvardmed |🇵🇪 MD @CayetanoHeredia | Interests: C.difficile, celiac disease, IBD, H.pylori, onco-GI
17-12-2010 17:41:08
2,9K Tweets
1,0K Followers
1,1K Following
🚨 New Cdiff trial alert! A study by Vedanta Biosciences found that VE303, a bacterial consortium of 8 Clostridia strains, may prevent recurrent CDI (rCDI) in high-risk adults! 🦠💊